Precordior leads integration of the advanced bed monitoring system developed in the Moore4Medical project in 2020–2023 for detection of atrial fibrillation during sleep. Heart failure monitoring and detection of coronary artery disease are also studied in the project.

EU funding will accelerate the development and global market entry preparation of the CardioSignal by Precordior® product family to include detection of Heart Failure and Coronary Artery Disease with built-in smartphone motion sensors, the new revolutionary smartphone-only technology.

The goal of the collaboration with Precordior is to further develop and deploy technology that detects symptoms of heart disease using a smartphone.